Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
European Journal of Human Genetics ; Volume: 9 ; Page: 355-363
Article in a journal
Journal of Medical Genetics ; Volume: 38 ; Page: 121-5
Article in a journal
Human Molecular Genetics ; Volume: 9 ; Page: 2223-2229
Article in a journal
Human Mutation ; Volume: 15 ; Page: 393-409
Article in a journal
Human Mutation ; Volume: 14 ; Page: 320-325
Article in a journal
Journal of Neuropathology and Experimental Neurology ; Volume: 58 ; Page: 867-880
Article in a journal
Genomics ; Volume: 57 ; Page: 144-151
Article in a journal
Human Molecular Genetics ; Volume: 7 ; Page: 1703-1712
Article in a journal
Journal of Medical Genetics ; Volume: 35 ; Page: 241-243
Article in a journal
Human Mutation ; Volume: 11 ; Page: 62-68
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
On
12/102025
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: